The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
104 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $76,954,546 in first-year total cost, median $500,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AN-P (11)]18
- Special Emphasis Panel[ZRG1 BP-C (10)]14
- Special Emphasis Panel[ZRG1 SCIL-D (10)]11
- Special Emphasis Panel[ZRG1 NV-H (13)]10
- Special Emphasis Panel[ZRG1 NV-G (13)]8
Most frequent institutions
- APPLIED UNIVERSAL DYNAMICS CORPORATION3
- EPICYPHER, INC.3
- AMISSA, INC.2
- BEAVER HEALTH, INC.2
- BELLAGE, INC.2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chronic toxicology studies in Wistar rats and Cynomolgus monkeys1R44AG092185-01A1 | JOHANSSON, JAN | ARTERY THERAPEUTICS, INC., CA | $2,454,521 | ZRG1 |
| 2025 | Evaluating the Health Benefits of Jigsawdio: A Novel Multisensory Jigsaw Puzzle-based Intervention for Alzheimer's Disease and Related Dementias2R44AG079736-02A1 | KIM, JUNHYOUNGMARQUINE, MARIAYOUNG, AMY | CALLAHAN-YOUNG LLC, NC | $1,565,997 | ZRG1 |
| 2025 | Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias2R44AG066325-04A1 | LE MAU, TUANPURDON, PATRICK L. | PASCALL SYSTEMS, INCORPORATED, MA | $1,499,986 | ZRG1 |
| 2025 | Wicked Smart Pad: Washable Sensorized Bedding for the Prevention and Detection of Moisture Events2R44AG078020-02 | TRUTTMANN, ALLISON | WICKED SHEETS, LLC, KY | $1,470,985 | ZRG1 |
| 2025 | NeuroSync: a data-driven, music-based augmented reality neurorehabilitation platform of games & puzzles to stimulate neuroplasticity and prolong functional independence in Alzheimer's Disease patients2R44AG081111-02 | GRAY, PETER | OUTLIER TECHNOLOGY, LLC, FL | $1,383,492 | ZRG1 |
| 2025 | 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development1R44NS143521-01 | DE MAJO, MARTINAGHAFFARI, LAYLA | SYNAPTICURE, INC., IL | $1,253,527 | ZRG1 |
| 2025 | AD04 disease-modifying drug for Alzheimer's - preclinical and IND-enabling studies1R44AG091827-01 | ABRAHAM, CARMELA R | ADVANTAGE THERAPEUTICS, INC, FL | $1,249,957 | ZRG1 |
| 2025 | Development of novel epigenetic biomarkers and detection reagents for aging1R44AG091990-01 | HUNT, SABRINA ROBIN | EPICYPHER, INC., NC | $1,249,147 | ZRG1 |
| 2025 | Single domain antibody development for improving vascular dysfunction in Alzheimer’s disease1R44AG097127-01 | HUSSAIN, SAZID | AIVOCODE, LLP, CA | $1,244,775 | ZAG1 |
| 2025 | Early detection and monitoring of Alzheimers Disease and Related Dementias using non-semantic linguistic and acoustic features of speech derived from hearing aids2R44AG080977-02A1 | BISCHOFF, BRIAN JOHNDEVAIAH, ANANDDING, HUITONG | HEADWATERS INNOVATION, INC., MN | $926,545 | ZRG1 |
| 2025 | LifeBio Memory: Development of a reminiscence therapy online platform with machine learning to increase engagement2R44AG069566-03A1 | OH, KYEUNG MISANDERS, LISBETH | LIFEBIO INC, OH | $907,141 | ZAG1 |
| 2025 | Imaging intracerebral and systemic T cell immunity in patients with Alzheimer's disease using 18F-F-AraG1R44AG094397-01 | LEVI, JELENA | CELLSIGHT TECHNOLOGIES, INC., CA | $871,261 | ZRG1 |
| 2025 | Smart driving technology for non-invasive detection of age-related cognitive decline2R44AG078063-02A1 | FORZANI, ERICA SILVIATSOW, FRANCIS | TF HEALTH CORPORATION, AZ | $831,790 | ZRG1 |
| 2025 | An Automated System for Caregivers and Staff to Locate Items Misplaced by Personswith Dementia in a Care Facility2R44AG065130-03A1 | GIBSON, PAUL | APPLIED UNIVERSAL DYNAMICS CORPORATION, MN | $649,281 | ZRG1 |
| 2025 | Novel Continuous Predictive Wearable Agitation Monitor and Alert Using Actigraphy and AI for Hospitalized Older Adults to Prevent Delirium and Dementia for Clinical Use and Harmonization of Research1R44AG097237-01 | PAVINI, MARIE T | HEALTHY DESIGN, LTD. CO., VT | $506,399 | ZAG1 |
| 2025 | Democratizing Early Detection and Longitudinal Monitoring of Alzheimer's Disease: An Ultra-Sensitive Blood-Based Assay1R43AG097403-01 | BADAY, MURATYANIK, AHMET ALI | REDWOOD NEURO INC., CA | $506,061 | ZAG1 |
| 2025 | An AI-based empathic virtual companion to track changing health states in persons living with dementia1R43AG091932-01 | SALOMON, MANDY | MENTIA DTX, INC., CA | $505,561 | ZRG1 |
| 2025 | YayaGuide: AI-Enabled Personalized Training for Caregivers of Older Adults with ADRD1R43AG094339-01 | SHAH, NEAL KAMAL | CAREYAYA HEALTH TECHNOLOGIES INC, NC | $505,042 | ZRG1 |
| 2025 | Imaging of Neurovascular Response for Assessment of Alzheimer's Disease1R41AG091877-01A1 | REGE, ABHISHEK | VASOPTIC MEDICAL, INC., MD | $500,000 | ZRG1 |
| 2025 | Confirming the use of aberrant T cells as an amyloid-independent blood biomarker for potentially earlier diagnosis and tracking the progression of Alzheimer's Disease1R43AG094412-01 | WHEELER, CHRISTOPHER JAY | T-NEURO, INC., NM | $500,000 | ZRG1 |
| 2025 | The SoundMind Smart Amplifier: An affordable, accessible, user-friendly hearing solution for persons with memory concerns and their family caregivers1R43AG094443-01 | GIBSON, PAUL | APPLIED UNIVERSAL DYNAMICS CORPORATION, MN | $499,993 | ZRG1 |
| 2025 | Demonstrating feasibility of using a robot to deliver a multicomponent intervention to reduce delirium in hospitalized elderly patients living with dementia1R43AG094367-01 | MALINSKY, YUVAL | VIGOROUS MIND, INC., MA | $499,981 | ZRG1 |
| 2025 | An Internet of Things Automated Cognitive Behavioral Therapy for Insomnia that Improves Cognition in Older Adults1R43AG097205-01 | GARTENBERG, DANIEL | PROACTIVE LIFE, INC., VA | $499,963 | ZAG1 |
| 2025 | TauTrace™: An ultrasensitive immunoassay for neurodegenerative protein biomarkers1R43AG094422-01 | BERGO, VLADISLAV | ADEPTRIX CORPORATION, MA | $499,940 | ZRG1 |
| 2025 | CaringGPT: Empowering Dementia Caregivers with Personalized and Accessible Resources to Match Their Needs, Enhance Cope with Caregiving, and Reduce Stress1R44AG094463-01A1 | KAJIYAMA, BRUNO | PHOTOZIG, INC., CA | $499,938 | ZAG1 |
| 2025 | Zinnia All Day: An application for mobile devices and connected TVs to assist care partners promote routine in activities of daily living in persons with Alzheimer's Disease and Related Dementias1R41AG087819-01A1 | SCHRIER, ALLYSONUNIOWSKI, WILLIAM | ZINNIA TECHNOLOGIES INC., IL | $499,898 | ZRG1 |
| 2025 | A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period1R44AG091987-01 | MOE, JAMES G. | OLIGOMERIX, INC, NY | $499,879 | ZRG1 |
| 2025 | Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers1R44AG091903-01 | CRIBBS, DAVID HASTINGSGHOCHIKYAN, ANAHIT | NURAVAX, INC., CA | $499,754 | ZRG1 |
| 2025 | Ecological Cognitive Monitoring through AI-Enhanced Personal Photo Activities1R43AG097223-01 | CHERNIN, LAWRENCE | DABBLE HEALTH, INC., CA | $499,686 | ZAG1 |
| 2025 | New Nanoprobes for MR Imaging of TrkB in Alzheimer's Disease1R44AG090240-01A1 | VITALIANO, FRANCOVITALIANO, GORDANA D. | EXQOR TECHNOLOGIES, INC., MA | $499,588 | ZAG1 |
| 2025 | Innovating a Personalized Reinforcement Interface to Motivate Engagement (PRIME) Among Care Partners for People Living with Alzheimer's Disease and Related Dementia in their Communities1R44AG097241-01 | YIN, DIANA | BELLAGE, INC., NY | $499,396 | ZAG1 |
| 2025 | Phase 0 Study to Evaluate the in vivo Characteristics of a Myeloperoxidase-Targeting PET Agent in Healthy Volunteers and Early AD Patients1R43AG092066-01 | WANG, DINGXIN | EINSENCA INC., DE | $497,878 | ZRG1 |
| 2025 | A Primary Care eConsult Platform for Dementia Diagnosis and Care Management1R43AG094410-01A1 | HUANG, BIN | BRAINCHECK, INC., TX | $497,782 | ZAG1 |
| 2025 | Developing Novel Ambroxol Analogs as Disease-Modifying Therapies for Alzheimer's Disease and Related Dementias1R43AG097283-01 | JOHNSTON, ROBERT | ZYWIE LLC, NV | $496,600 | ZAG1 |
| 2025 | Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's Disease1R44AG090144-01A1 | GRESACK, JODI ELLEN | PSYCHOGENICS, INC., NJ | $495,699 | ZAG1 |
| 2025 | Activites4Care: A Digital Platform to Enhance Caregiver Well-being by Providing Customized Activities that Improve Quality of Life for People Living with Dementia1R44AG091857-01 | GITLIN, LAURA N.KOEUTH, SOKHA | PLANS4CARE INC., RI | $490,262 | ZRG1 |
| 2025 | SynG: a Music-Based Intervention for Alzheimer's and Mild Cognitive Impairment1R43AG092067-01 | LARGE, EDWARD WLOUI, PSYCHE | OSCILLOSCAPE, LLC, CT | $467,538 | ZRG1 |
| 2025 | Development of a RUNX1 modulator to slow cognitive decline in Alzheimer's disease1R43AG087766-01A1 | PALMER, CARTER RODMAN | THIRD ELEMENT BIO INC., CA | $391,850 | ZRG1 |
| 2025 | Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease1R43AG090243-01A1 | LLOYD, LINDA S | STRESS THERAPEUTICS, INC., CA | $349,605 | ZRG1 |
| 2025 | SeeInMe: Digital Profiles Facilitating Person-centered Coordinated Care for People with Dementia1R43AG090142-01A1 | STEIN, RISAWILLIAMS, KRISTINE N. | SEEINME INC, MO | $326,382 | ZRG1 |
| 2025 | Home-based plasma self-collection device for remote diagnosis and monitoring of AD-associated biomarkers1R43AG097214-01 | VEMULAPATI, SASANK | LO BIOSCIENCES, INC., MD | $305,621 | ZAG1 |
| 2025 | Identification of next generation gamma-secretase modulators for Alzheimer's disease1R41AG094356-01A1 | CALVIER, LAURENTHERZ, JOACHIM JKOUNNAS, MARIA Z | REELIN THERAPEUTICS, INC., CA | $258,213 | ZAG1 |
| 2024 | Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease1R44AG085775-01A1 | MAHER, PAMELA ANNERASCHKE, WILLIAM C | VIROGENICS, INC., CA | $2,432,649 | ZRG1 |
| 2024 | Direct protein phosphatase 2A (PP2A) activators as novel Alzheimer’s Disease (AD) therapeutics2R44AG071040-02 | OHLMEYER, MICHAEL | ATUX ISKAY GROUP LLC, NJ | $1,688,077 | ZRG1 |
| 2024 | Empowering Advanced Alzheimers Disease and Dementia Research Through Remote Patient Monitoring and Cloud-Connected Wearable Devices2R44AG072981-02A1 | CORKEY, JON ANDREW | AMISSA, INC., NC | $1,419,714 | ZRG1 |
| 2024 | A Synapse-Protecting Small Peptide to Treat a-Syn/Tau Mixed Proteinopathies in Alzheimer's Disease Related Dementias (ADRD)2R44AG074715-02A1 | RUFF, MICHAEL R | CREATIVE BIO-PEPTIDES, INC., MD | $1,381,306 | ZRG1 |
| 2024 | Validation of a novel EEG-based neurodiagnostic platform for assessing cognitive impairment and Alzheimer's Disease2R44AG078039-02 | LUCERO, CHE | SPARK NEURO INC., NY | $1,338,700 | ZRG1 |
| 2024 | Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts1R44AG087752-01 | HUNT, SABRINA ROBINVENTERS, BRYAN J | EPICYPHER, INC., NC | $1,274,993 | ZRG1 |
| 2024 | Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research1R44AG090112-01 | VENTERS, BRYAN J | EPICYPHER, INC., NC | $1,274,632 | ZRG1 |
| 2024 | Active-H2O: Sensor driven smart faucet to empower independent living for individuals impacted by Alzheimers disease and dementia1R44AG087731-01 | OKHRAVI, HAMID REZAWADDELL, JOHN STEVEN | NASONI LLC, VA | $1,249,235 | ZRG1 |
| 2024 | Preventing Medication Mismanagement in People Living with Dementia through Automated Medication Dispensing with Facial Recognition and Video Observation2R44AG077737-02 | AGGARWAL, NEELUM T.GELLMAN, CHARLES | HIDO TECHNOLOGIES, INC., CA | $1,243,618 | ZRG1 |
| 2024 | Development of perivascular space mapping toolset as a diagnostic aid for Alzheimer's disease1R44AG087855-01 | CHOUPAN, JEIRAN | NEUROSCOPE INC., NY | $1,193,370 | ZRG1 |
| 2024 | Onward Door-Through-Door Companion Rideshare Technology to Improve Care for Older Adults and Individuals with Alzheimer's Disease and Related Dementias (AD/ADRD)1R44AG085945-01A1 | WACHTER PETTY, KIMBERLY | ONWARD HEALTH, INC, CA | $1,165,908 | ZRG1 |
| 2024 | EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE1R44AG087853-01A1 | DEWJI, NAZNEEN N | CENNA BIOSCIENCES, INC., CA | $1,041,646 | ZRG1 |
| 2024 | Development of a novel Alzheimer's disease therapeutic targeting tau2R44AG060843-04 | LARSEN, GLENNWOLOZIN, BENJAMIN L | AQUINNAH PHARMACEUTICALS, INC., MA | $999,721 | ZRG1 |
| 2024 | Single-cell Epigenome Analysis of the Alzheimer's Disease Brain2R44AG079691-02 | HARTL, CHRISTOPHER | EPIGENOME TECHNOLOGIES, INC., CA | $995,100 | ZRG1 |
| 2024 | Olera CareNavigator - Increasing Affordability and Accessibility of Senior Care For Dementia Family Caregivers2R44AG074116-04 | FALOHUN, TOKUNBO | OLERA INC., TX | $963,410 | ZRG1 |
| 2024 | The BRAIN App: Building Relationships using Artificial Intelligence and Nostalgia2R44AG071105-03 | SKRAJNER, MICHAEL JOHN | HOPEFUL AGING LLC, MA | $878,369 | ZRG1 |
| 2024 | Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease2R44AG063589-02 | ILIUK, ANTON | TYMORA ANALYTICAL OPERATIONS, LLC, IN | $815,028 | ZRG1 |
| 2024 | A Gait and Path Tortuosity System for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)2R44AG063679-02 | CONDON, JOHN PAUL | INNOVATIVE DESIGN LABS, INC., MN | $705,763 | ZRG1 |
| 2024 | On-Chip Assay for Identifying Candidate Microtubule Binding Drugs to Treat ADRDs1R43AG085842-01A1 | KARSTEN, STANISLAV | NEUROINDX INC., CA | $514,862 | ZRG1 |
| 2024 | Augmented Preclinical Alzheimer's Disease Detection Through Wearable Health and Driving Behavior Data.1R43AG087803-01A1 | CORKEY, JON ANDREW | AMISSA, INC., NC | $505,516 | ZRG1 |
| 2024 | Interactive Gaming Platform to Facilitate Cognitive Interventions for Dementia1R43AG090220-01 | RIEHLE, TIMOTHY H. | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $505,184 | ZRG1 |
| 2024 | A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment1R44AG085858-01 | BROWN, JEFFREY M. | SENSORIUM THERAPEUTICS INC, MA | $502,499 | ZRG1 |
| 2024 | Development of Novel Small molecule modulators of synaptic plasticity for the treatment of AD-induced cognitive decline1R43AG087761-01A1 | LOFFLER, ALICIA | ENCUE INC., IL | $499,998 | ZRG1 |
| 2024 | COMPASS: A Family-Centered, Culturally Responsive Conversational AI Assistant to Support ADRD Caregivers and Family Care Networks in Real-Time1R43AG087829-01A1 | WANG, EMILY S. | BEAVER HEALTH, INC., CA | $499,996 | ZRG1 |
| 2024 | Optimization of Novel Potassium Channel Kv1.3 Blockers with Potential as Alzheimer's Disease Therapeutics1R43AG085864-01A1 | BUTERA, JOHN A | HAGER BIOSCIENCES, LLC, PA | $499,968 | ZRG1 |
| 2024 | A Personalized and Culturally Responsive Mindfulness Virtual Coach to Support Dementia Caregivers1R43AG085865-01A1 | WANG, EMILY S. | BEAVER HEALTH, INC., CA | $499,961 | ZRG1 |
| 2024 | Automated System for Detecting and Reporting Lapses in Performance of Activities of Daily Living for Independent and Cohabitating Persons with Alzheimer's Disease and Related Dementias1R43AG085709-01 | SHEIKH, SUNEEL ISMAIL | ASTER LABS, INC., MN | $499,758 | ZRG1 |
| 2024 | A novel closed-loop feedback neuromodulation system for improving slow wave sleep in Alzheimer's disease patients1R43AG084379-01A1 | KROHN, BRIAN | SYNAPTIC HEALTH LLC, MN | $499,386 | ZRG1 |
| 2024 | Innovative web-based service platform called Adult Wellbeing CheckUp (AWC) to assess older adults wellbeing, obtain evidence-based recommendations, and receive support to take action1R44AG082602-01A1 | FIRMAN, JAMES P | BELLAGE, INC., NY | $497,829 | ZRG1 |
| 2024 | Targeting biologically relevant tau monomers and oligomers using a novel DEL drug discovery platform to treat Alzheimer’s disease and tauopathies1R43AG085856-01A1 | FLAJOLET, MARC | JILLION THERAPEUTICS INC., NY | $496,373 | ZRG1 |
| 2024 | Leveraging high-throughput functional data for assessment of Alzheimer's risk1R43AG084431-01A1 | SCHAFER, NICHOLAS | CONSTANTIAM BIOSCIENCES INC., TX | $485,192 | ZRG1 |
| 2024 | LifeBioTALK: Digital Engagement with a Pre-Scripted Avatar for People with Alzheimer's Disease to Reduce Challenging Behaviors and Caregiver Burden1R43AG082588-01A1 | SANDERS, LISBETH | LIFEBIO INC, OH | $432,337 | ZRG1 |
| 2024 | Connection, Independence, and Circular Support: Prompted Health Awareness Enabled by the At-Home Health Station1R43AG082596-01A1 | MAZUR, ROBERT | B A MAZE, INC., KY | $405,614 | ZRG1 |
| 2024 | Cell-based RNA degradation assay for C9ALS/FTD drug discovery1R43AG085837-01 | O'HANLON, RYAN | LUCERNA, INC., NY | $392,116 | ZRG1 |
| 2024 | Chair to Prevent and Treat Pressure Injuries in Persons Living with Alzheimer's Disease and Related Dementias1R43AG087785-01 | GRACI,, VALENTINASEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $356,548 | ZRG1 |
| 2024 | Neuroprotective Engineered Bacteria for Alzheimer's Disease Treatment1R43AG087824-01A1 | MIANO, ARIANNA | BLOOM SCIENCE, INC., CA | $283,673 | ZRG1 |
| 2024 | Targeting Type 3 Diabetes (T3D) Mechanism of Alzheimer's Disease (AD) and AD-Related Dementias1R43AG085738-01 | EYERMANN, CHARLES JOSEPHSUVOROV, ALEXANDER | REGENE LLC, MA | $249,995 | ZRG1 |
| 2024 | Computer vision powered automation of rodent arena for assessment of early Alzheimer's disease.1R43AG090213-01 | CHEN, DONG FENGLUO, GANGTOMASI, MATTEO | EYENEXO LLC, MA | $245,148 | ZRG1 |
| 2024 | A Mobile Informatics Solution to Assist Caregivers with Care Coordination and Social Engagement2R44AG063683-04 | HAVEY, GARY D | ADVANCED MEDICAL ELECTRONICS CORPORATION, MN | $114,957 | ZRG1 |
| 2023 | GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development forADRD2R44AG066384-03 | MOE, JAMES G. | OLIGOMERIX, INC, NY | $1,496,276 | ZRG1 |
| 2023 | Whole blood filter paper assay for Alzheimers Disease2R44AG065039-02A1 | SELIGMANN, BRUCE E. | BIOSPYDER TECHNOLOGIES, INC., CA | $1,421,226 | ZRG1 |
| 2023 | A high throughput multiplexed pipeline for models of Alzheimer’s Disease1R44AG084491-01 | RAGAN, TIMOTHY M. | TISSUEVISION, INC., MA | $1,249,017 | ZRG1 |
| 2023 | Spatial single cell analysis of the human Alzheimer's Disease brain1R44AG085832-01 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC., CA | $1,229,313 | ZRG1 |
| 2023 | Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's Disease1R44AG078038-01A1 | SNINSKY, JOHN JOSEPH | SUPERFLUID DX, INC., CA | $1,086,079 | ZRG1 |
| 2023 | SAGE LEAF 2: An Online Self-Guided Positive Emotion Regulation Program to Reduce Alzheimer's Dementia Caregiver Burden Delivered through Caregiver-Serving Organizations2R44AG065080-03 | MOSKOWITZ, JUDITH T.YANG, DERSHUNG | BRIGHTOUTCOME INC., IL | $870,860 | ZRG1 |
| 2023 | Novel Extracorporeal Device 'Amytrapper' To Remove Beta Amyloid In Alzheimer'sDisease2R44AG057327-04 | SUNDARAM, PAZHANI | RECOMBINANT TECHNOLOGIES, LLC, CT | $806,673 | ZRG1 |
| 2023 | Using Structured Light Sensing with Machine Learning to Detect Unwitnessed In-Home Falls2R44AG066263-02A1 | GIBSON, PAUL | APPLIED UNIVERSAL DYNAMICS CORPORATION, MN | $768,585 | ZRG1 |
| 2023 | ADVANCED COMPREHENSIVE MAGNETIC RESONANCE SOLUTION FOR THE NONINVASIVE CHARACTERIZATION OF HIGH RESOLUTION METABOLIC BIOMARKERS OF RISK IN PATIENTS WITH ALZHEIMER'S DISEASE AND DEMENTIA1R44AG085817-01 | SRINIVASAN, RAVI | ADVANCED IMAGING RESEARCH, INC., OH | $569,853 | ZRG1 |
| 2023 | Implementing and Scaling the STEADI Fall Prevention Algorithm Using a Conversational Relational Agent for Community-Dwelling Older Adults with and without Mild Cognitive Impairment (MCI).1R44AG085913-01 | KERSSENS, CHANTAL M | CARE.COACH CORPORATION, CA | $544,163 | ZRG1 |
| 2023 | A Multi-Modal Wearable Sensor for Early Detection of Cognitive Decline and Remote Monitoring of Cognitive-Motor Decline Over Time1R44AG084487-01 | NAJAFI, BIJANVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $500,011 | ZRG1 |
| 2023 | Plans4Care: Personalized Dementia Care On-Demand1R44AG084365-01 | JUTKOWITZ, ERICKOEUTH, SOKHA | PLANS4CARE INC., RI | $500,000 | ZRG1 |
| 2023 | Human Neural Organoid Modeling of Alzheimer's Disease Neuroinflammation for Drug Discovery1R43AG082625-01A1 | LEBAKKEN, CONNIE S | STEM PHARM, INC., WI | $499,903 | ZRG1 |
| 2023 | GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular1R43AG085713-01 | HAY, MEREDITHRILEY, JEREMY | PRONEUROGEN, INC., AZ | $499,545 | ZRG1 |
| 2023 | Ultra Wideband Fall Detection and Prediction Solution for People Living with Dementia1R44AG076218-01A1 | SYMONDS, SHELLEY L | CLAIRVOYANT NETWORKS, INC., TX | $495,902 | ZRG1 |
| 2023 | Recharge Behavioral Therapy for caregivers of individuals with Alzheimer's Disease1R44AG084419-01 | KAJIYAMA, BRUNO | PHOTOZIG, INC., CA | $493,406 | ZRG1 |
| 2023 | Innovative Chair to Prevent Pressure Injuries in Persons Living with Alzheimer's Disease and Related Dementias1R43AG084411-01 | LUNDSTROM, JULIESEFCIK, JUSTINE SUZETTE | RUSH RIVER RESEARCH CORPORATION, WI | $375,704 | ZRG1 |
| 2023 | Neurosessments: Developing a quick, objective motor test to prompt cognitivetesting in primary care1R43AG082604-01A1 | LOVE, JILL WINQUIST | NEUROSESSMENTS LLC, AZ | $345,604 | ZRG1 |
| 2023 | A novel driving coach app for older adults with cognitive impairment1R43AG084374-01 | EHSANI, POUYA JOHNATHONKRAMER, KEVIN M. | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $343,030 | ZRG1 |
| 2023 | PET Imaging to Evaluate a Novel Chemokine Antagonist to Protect Synapses in ADRD1R43AG085779-01 | RUFF, MICHAEL R | CREATIVE BIO-PEPTIDES, INC., MD | $324,790 | ZRG1 |
| 2023 | Discovery and development of OGG1 activators as precision drugs for modification of Alzheimer's disease progression.1R43AG084412-01 | RUMSEY, WILLIAM L | LUCIOLE PHARMACEUTICALS, INC., MA | $303,509 | ZRG1 |
| 2023 | Assessment Validation1R43AG082615-01A1 | O'HALLORAN, JAMES P | NEUROCOMP SYSTEMS, INC., CA | $266,035 | ZRG1 |
| 2023 | Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function1R43AG084450-01 | CALVIER, LAURENTHERZ, JOACHIM JKOUNNAS, MARIA Z | REELIN THERAPEUTICS, INC., CA | $259,999 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.